DOES TESTING FOR SAA IS MORE BENEFICIAL THAN CRP FOR THE FOLLOW-UP OF FMF PATIENTS WITH M694V HETEROZYGOUS OR M694V HOMOZYGOUS MUTATIONS?

Oztas M., Ugurlu S., Selvi O., Ergezen B., Ozdogan H.

Annual European Congress of Rheumatology (EULAR), ELECTR NETWORK, 03 June 2020, vol.79, pp.843, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Volume: 79
• Doi Number: 10.1136/annrheumdis-2020-eular.5625
• Country: ELECTR NETWORK
• Page Numbers: pp.843
• Istanbul University Affiliated: Yes